Characterization of the susceptibility of mycobacteria in BACTEC 12B media containing PANTA that had been supplemented with ceftazidime, and characterization of the individual components of PANTA in the presence of C 18-carboxypropylbetaine

Journal of Microbiological Methods

Volumn 56, Issue 2, 2004, Pages 243-251

  Thornton, Charles G ^a   MacLellan, Kerry M ^a   Brink Jr , Thomas L ^a   Passen, Selvin ^a  

^a QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

Author keywords

C18 Carboxypropylbetaine; Mycobacteria; Specimen processing

Indexed keywords

AZLOCILLIN; BETAINE DERIVATIVE; C18 CARBOXYPROPYLBETAINE; CEFTAZIDIME; NALIDIXIC ACID; TRIMETHOPRIM; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DILUTION; GENETIC SUSCEPTIBILITY; GENETIC TRAIT; MYCOBACTERIOSIS; MYCOBACTERIUM; MYCOBACTERIUM AVIUM; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM KANSASII; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

CORYNEBACTERINEAE; MYCOBACTERIUM; MYCOBACTERIUM AVIUM; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM KANSASII; MYCOBACTERIUM TUBERCULOSIS;

EID: 1642523429     PISSN: 01677012     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mimet.2003.10.020     Document Type: Article

References (11)

1. Conville P.S., Andrews J.W.B., Witebsky F.G. Effect of PANTA on growth of Mycobacterium kansasii in BACTEC 12B medium. J. Clin. Microbiol. 33:1995;2012-2015.
2. 18-carboxypropylbetaine and glass bead DNA extraction methods for detection of Mycobacterium bovis in bovine milk samples and analysis of samples by PCR. Appl. Environ. Microbiol. 64:1998;3099-3101.
3. Hui J., Gordon N., Kajioka R. Permeability barrier to rifampin in mycobacteria. Antimicrob. Agents Chemother. 5:1977;773-779.
4. Kent P.T., Kubica G.P. Public Health Mycobacteriology. A Guide for the Level III Laboratory. 1985;Centers for Disease Control and Prevention, Atlanta, GA.
5. Laserson K.F., Yen N.T.N., Thornton C.G., An D.Q., Phuoc N.H., Trinh N.A., Nhung D.T.C., Mai V.T.C., Jones W., Wells C., Cetron M., Maloney S.A. Improvement in sputum smear sensitivity following processing with C18-carboxypropylbetaine in US-bound immigrants from Viet Nam. 4th World Congress on Tuberculosis. 2002;79 National Institutes of Health in Bethesda, Maryland, USA. Absract #131.
6. 18-carboxypropylbetaine specimen processing method using the MB/BacT liquid culture system. Eur. J. Clin. Microbiol. Infect. Dis. 22:2003;35-42.
7. Thornton, C.G., 1997. Method for processing mycobacteria, U.S. patent 5,658,749.
8. Thornton, C.G., 2002. Betaines as adjuvants to susceptibility testing and antimicrobial therapy. U.S. patent 6,406,880.
9. 18-carboxypropylbetaine: blinded study. J. Clin. Microbiol. 36:1998;1996-2003.
10. 18- carboxypropylbetaine: development of a sediment resuspension buffer that contains lytic enzymes to reduce the contamination rate and lecithin to alleviate toxicity. J. Clin. Microbiol. 36:1998;2004-2013.
11. 18-carboxypropylbetaine for processing of specimens for recovery of mycobacteria. J. Clin. Microbiol. 36:1998;3558-3566.